Therapies in the Pipeline for Primary Biliary Cholangitis 2024

Description

Experts in this interactive, small group discussion present the most up-to-date pipeline for drug development in primary biliary cholangitis (PBC). Speakers address the indications for second-line therapy in PBC; the proposed benefits of various drugs in development and differences in their expected mechanisms of action; and potential management algorithms, considering risks and benefits of each drug. This session provides attendees the opportunity to hold informal conversations with key thought leaders in the field.